ARS Pharmaceuticals, Inc. (SPRY)

CIK 1671858 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for ARS Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Sep 11, 20261440001950047-26-009340
Sep 11, 20261440001950047-26-009329
Sep 4, 20261440001950047-26-009120
Sep 3, 20261440001950047-26-009066
Sep 2, 20261440001950047-26-009041
Sep 2, 202640002149973-26-000004
Sep 1, 20261440001950047-26-008961
Aug 31, 20261440001950047-26-008852
Aug 20, 20261440001950047-26-008488
Aug 20, 20261440001950047-26-008459
Aug 19, 20261440001950047-26-008376
Aug 19, 20261440001950047-26-008389
Aug 18, 20261440001950047-26-008357
Aug 18, 20261440001950047-26-008362
Aug 17, 202630002149973-26-000002
Aug 13, 20268-K0001193125-26-349127
Aug 13, 202610-Q0001193125-26-349140
Jul 27, 2026SCHEDULE 13G0002012383-26-002251
Jul 17, 20268-K0001193125-26-307773
Jul 14, 2026SCHEDULE 13G/A0001104659-26-083589
Jul 7, 20268-K0001193125-26-297554
Jul 2, 202640002135296-26-000007
Jun 26, 202640001575408-26-000002
Jun 26, 202640001357522-26-000005
Jun 26, 202640001551891-26-000002